Ioannis Koutroubakis

Dr. Ioannis Koutroubakis

University Hospital Heraklion
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2015 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
PDF file
MHMarcus Harbord
Marcus Harbord
VAVito Annese
Vito Annese
SVStephan R. Vavricka
Stephan R. Vavricka
MAMatthieu Allez
Matthieu Allez
MAManuel Barreiro-De Acosta
Manuel Barreiro-De Acosta
C(Colitis Organisation (Ecco)
Colitis Organisation (Ecco)

16 January 2015 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
PDF file
ADAxel Dignass
Axel Dignass
CGChristopher Gasche
Christopher Gasche
DBDominik Bettenworth
Dominik Bettenworth
GBGunnar Birgegård
Gunnar Birgegård
SDSilvio Danese
Silvio Danese
SVStephan Vavricka
Stephan Vavricka

1 December 2007 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
CGChristoph Gasche
Christoph Gasche
ABArnold Berstad
Arnold Berstad
RBRagnar Befrits
Ragnar Befrits
CBChristoph Beglinger
Christoph Beglinger
ADAxel Dignass
Axel Dignass
GAGert Van Assche
Gert Van Assche

1 February 2006 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
KKKonstantinos Karmiris
Konstantinos Karmiris
IKIoannis Koutroubakis
Ioannis Koutroubakis
CXCostas Xidakis
Costas Xidakis
MPMaria Polychronaki
Maria Polychronaki
TVTheodora Voudouri
Theodora Voudouri
EKElias A Kouroumalis
Elias A Kouroumalis
There is evidence that adipocytokines play an important role in metabolism and in inflammation. Because human metabolism dramatically changes in inflammatory bowel disease (IBD) and chronic inflammation is the hallmark of the disease, we studied serum levels of leptin, adiponectin, resistin, and ghrelin in patients with ulcerative colitis (UC) and Crohn's disease (CD) in comparison with healthy controls (HC). Leptin, adiponectin, resistin, and active ghrelin serum levels were measured in 100 IBD patients (46 UC and 54 CD) and in 60 matched HC using commercially available enzyme-linked immunosorbent assays. Leptin, adiponectin, resistin, and ghrelin levels were correlated with disease activity, type, localization, and treatment. Mean serum leptin levels were 10.6+/-2.0 ng/mL in UC patients, 12.5+/-2.6 ng/mL in CD patients, and 15.0+/-1.8 ng/mL in HC (P=.01). Mean serum adiponectin levels were 9514.8+/-787.8 ng/mL in UC patients, 7651.1+/-613 ng/mL in CD patients, and 7270.6+/-559.4 ng/mL in HC (P=.05). Mean serum resistin levels were 21.2+/-2.2 ng/mL in UC patients, 18.7+/-1.6 ng/mL in CD patients and 11.8+/-0.6 ng/mL in HC (P=.0002). Mean serum ghrelin levels were 48.2+/-4.2 pg/mL in UC patients, 49.4+/-4.6 pg/mL in CD patients and 14.8+/-3.0 pg/mL in HC (P<.0001). Serum levels of these adipocytokines were not correlated with either C-reactive protein levels or the clinical indices of activity. No association between serum adipocytokines levels and disease localization in both UC and CD patients was found. Only serum ghrelin was significantly higher in ileal compared with colonic CD (P=.04). Serum levels of adiponectin, resistin, and active ghrelin are increased whereas serum levels of leptin are decreased in patients with IBD. Further studies are needed to elucidate the role of adipocytokines in IBD.

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ΑTΑngeliki Theodoropoulou
Αngeliki Theodoropoulou
IKIoannis Koutroubakis
Ioannis Koutroubakis
Ischemic colitis is the most common form of ischemic injury of the gastrointestinal tract and can present either as an occlusive or a non-occlusive form. It accounts for 1 in 1000 hospitalizations but its incidence is underestimated because it often has a mild and transient nature. The etiology of ischemic colitis is multifactorial and the clinical presentation variable. The diagnosis is based on a combination of clinical suspicion, radiographic, endoscopic and histological findings. Therapy and outcome depends on the severity of the disease. Most cases of the non-gangrenous form are transient and resolve spontaneously without complications. On the other hand, high morbidity and mortality and urgent operative intervention are the hallmarks of gangrenous ischemic colitis.

16 December 2005 in Gut
Verified
Journal Article
Open access
PDF file
FWF L Wolters
F L Wolters
MRM G Russel
M G Russel
JSJ Sijbrandij
J Sijbrandij
TAT Ambergen
T Ambergen
SOS Odes
S Odes
BMB Moum
B Moum
Background: In Crohn’s disease (CD), studies associating phenotype at diagnosis and subsequent disease activity are important for patient counselling and health care planning. Aims: To calculate disease recurrence rates and to correlate these with phenotypic traits at diagnosis. Methods: A prospectively assembled uniformly diagnosed European population based inception cohort of CD patients was classified according to the Vienna classification for disease phenotype at diagnosis. Surgical and non-surgical recurrence rates throughout a 10 year follow up period were calculated. Multivariate analysis was performed to classify risk factors present at diagnosis for recurrent disease. Results: A total of 358 were classified for phenotype at diagnosis, of whom 262 (73.2%) had a first recurrence and 113 patients (31.6%) a first surgical recurrence during the first 10 years after diagnosis. Patients with upper gastrointestinal disease at diagnosis had an excess risk of recurrence (hazard ratio 1.54 (95% confidence interval (CI) 1.13–2.10)) whereas age ⩾40 years at diagnosis was protective (hazard ratio 0.82 (95% CI 0.70–0.97)). Colonic disease was a protective characteristic for resective surgery (hazard ratio 0.38 (95% CI 0.21–0.69)). More frequent resective surgical recurrences were reported from Copenhagen (hazard ratio 3.23 (95% CI 1.32–7.89)). Conclusions: A mild course of disease in terms of disease recurrence was observed in this European cohort. Phenotype at diagnosis had predictive value for disease recurrence with upper gastrointestinal disease being the most important positive predictor. A phenotypic North-South gradient in CD may be present, illustrated by higher surgery risks in some of the Northern European centres.